ASHBURN, Va., April 30 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last of three planned phase 2 clinical trials sponsored by its wholly owned ...
CollaRx GENTAMICIN TOPICAL represents the clinical development of the marketed GENTAMICIN SURGICAL IMPLANT for the topical treatment and prevention of infection in chronic skin ulcers, such as ...
In 1968-1969, there was an outbreak of colonization with gentamicin-resistant, Pseudomonas aeruginosa, pyocine type 5, in the burn service at Grady Hospital. Although the means by which resistance was ...
Pharma ASHBURN, Va., Sept. 6 -- Innocoll, Inc. announced that it has agreed the sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European sales and marketing infrastructure to EUSA Pharma Inc., ...
It is widely documented that aminoglycosides, including gentamicin, are nephrotoxic to the proximal renal tubules, with an incidence ranging widely from 2% to 50%, depending on the source.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results